Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity - Bamodu, O A; Huang, W C; Tzeng, D T; Wu, A; Wang, L S; Yeh, C T; Chao, T Y (Cancer Lett, 2015)